CRT 2026

EVENING SYMPOSIUM | CRT-SCAI JOINT SESSION | INTERVENTIONAL CARDOLOGY FELLOWSHIP PROGRAM DIRECTOR'S SUMMIT

Moderator(s)

• 

  Itsik Ben-Dor, MD

  WHC
  MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Douglas E. Drachman, MD, MSCAI

  Director of Education and Director of Interventional Cardiology Fellowship Program
  Massachusetts General Hospital
  Boston, Massachusetts, United States

  Disclosure(s): Abiomed;: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Grant W. Reed, MD, MSc

  Program Director, Interventional Cardiology Fellowship
  Cleveland Clinic
  Cleveland, Ohio, United States

  Disclosure(s): Abbott Laboratories: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

• 

  J. Dawn Abbott, MD

  Director, Interventional Cardiology Brown University Health Cardiovascular Institute Director, Cardiac Catheterization Laboratories at Rhode Island and The Miriam Associate Chief, Faculty Development and Academic Advancement Professor of Medicine ,Warren Alpert Medical School, Brown University
  Brown University
  Providence, Rhode Island, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Med Alliance: Grant/Research Support (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordisk: Grant/Research Support (Ongoing)
• 

  Tayo A. Addo, MD

  Professor
  The University of Texas Southwestern Medical Center
  DALLAS, Texas, United States

  Disclosure(s): No financial relationships to disclose
• 

  Ryan D. Madder, MD

  Program Director, Interventional Cardiology Fellowship
  Corewell Health East/William Beaumont University Hospital
  Northville, Michigan, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus Vascular Robotics: Consulting Fees (e.g., advisory boards) (Terminated), Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Orchestra Biomed: Consulting Fees (e.g., advisory boards) (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Srihari S. Naidu, MD, MSCAI

  Director, Cath Labs and HCM Program
  Westchester Medical Center
  Valhalla, New York, United States

  Disclosure(s): No financial relationships to disclose
• 

  Sahil A. Parikh, MD, FSCAI

  Associate Professor of Medicine
  Columbia University Irving Medical Center
  New York, New York, United States

  Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Advanced NanoTherapies: Stock Options [in privately held companies] (Ongoing); AVS: Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Concept Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Encompass vascular: Stock Options [in privately held companies] (Ongoing); Fastwave: Grant/Research Support (Ongoing); Inari/Stryker: Consulting Fees (e.g., advisory boards) (Ongoing); Medinol: Grant/Research Support (Ongoing); Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); R3 Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Sailaja Pindiprolu, MD

  Program Director Medicine and Associate DIO
  MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Prashanth D. Thakker, MD, MHPE, FACC, FSCAI

  Assistant Professor
  Washington University in St. Louis
  Saint Louis, Missouri, United States

  Disclosure(s): Abiomed Inc: Consulting Fees (e.g., advisory boards) (Ongoing)